Correction to: Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma (Molecular Imaging and Biology, (2021), 23, 2, (186-195), 10.1007/s11307-020-01542-4)
Dive into the research topics of 'Correction to: Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma (Molecular Imaging and Biology, (2021), 23, 2, (186-195), 10.1007/s11307-020-01542-4)'. Together they form a unique fingerprint.